Sichenzia Ross Friedman Ference LLP Represents LaidLaw & Company (UK) Ltd. on $5.0M Registered Direct Offering of Actinium Pharmaceuticals, Inc
June 18, 2015 – New York, NY – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the sole placement agent Laidlaw & Company (UK) in a registered direct offering of Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM), a biopharmaceutical company developing innovative targeted immunotherapeutics for the treatment of advanced cancers. The offering consisted of 1,923,078 shares of the Company’s common stock issued at a purchase price of $2.60 per share for aggregate gross proceeds ofapproximately $5,000,000.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Richard A. Friedman and Stephen A. Cohen
- Sichenzia Ross Ference LLP Represents BriaCell Therapeutics Corp. in Nasdaq listing and $25 Million Public Offering - February 26, 2021
- Sichenzia Ross Ference LLP Represents AmpliTech Group, Inc. in Nasdaq Uplisting and $11 Million Upsized Public Offering - February 25, 2021
- Sichenzia Ross Ference LLP Represents CloudCommerce, Inc. in $10.0 Million Registered Direct Offering - February 23, 2021